Related references
Note: Only part of the references are listed.Survival of motor neurone protein is required for normal postnatal development of the spleen
Alison K. Thomson et al.
JOURNAL OF ANATOMY (2017)
Neurocalcin Delta Suppression Protects against Spinal Muscular Atrophy in Humans and across Species by Restoring Impaired Endocytosis
Markus Riessland et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2017)
The Power of Human Protective Modifiers: PLS3 and CORO1C Unravel Impaired Endocytosis in Spinal Muscular Atrophy and Rescue SMA Phenotype
Seyyedmohsen Hosseinibarkooie et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2016)
Vascular Defects and Spinal Cord Hypoxia in Spinal Muscular Atrophy
Eilidh Somers et al.
ANNALS OF NEUROLOGY (2016)
Histopathological Defects in Intestine in Severe Spinal Muscular Atrophy Mice Are Improved by Systemic Antisense Oligonucleotide Treatment
Palittiya Sintusek et al.
PLOS ONE (2016)
Systemic peptide-mediated oligonucleotide therapy improves long-term survival in spinal muscular atrophy
Suzan M. Hammond et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Survival Motor Neuron (SMN) protein is required for normal mouse liver development
Eva Szunyogova et al.
SCIENTIFIC REPORTS (2016)
Systemic restoration of UBA1 ameliorates disease in spinal muscular atrophy
Rachael A. Powis et al.
JCI INSIGHT (2016)
A Large Animal Model of Spinal Muscular Atrophy and Correction of Phenotype
Sandra I. Duque et al.
ANNALS OF NEUROLOGY (2015)
Moving towards treatments for spinal muscular atrophy: hopes and limits
Brunhilde Wirth et al.
EXPERT OPINION ON EMERGING DRUGS (2015)
PTEN Depletion Decreases Disease Severity and Modestly Prolongs Survival in a Mouse Model of Spinal Muscular Atrophy
Daniel Little et al.
MOLECULAR THERAPY (2015)
Systemic AAVrh10 provides higher transgene expression than AAV9 in the brain and the spinal cord of neonatal mice
Yannick Tanguy et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2015)
Intracisternal delivery of AAV9 results in oligodendrocyte and Motor neuron transduction in the whole central nervous system of cats
T. Bucher et al.
GENE THERAPY (2014)
Chondrolectin affects cell survival and neuronal outgrowth in in vitro and in vivo models of spinal muscular atrophy
James N. Sleigh et al.
HUMAN MOLECULAR GENETICS (2014)
Dysregulation of ubiquitin homeostasis and β-catenin signaling promote spinal muscular atrophy
Thomas M. Wishart et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Requirement of enhanced Survival Motoneuron protein imposed during neuromuscular junction maturation
Shingo Kariya et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Intramuscular scAAV9-SMN Injection Mediates Widespread Gene Delivery to the Spinal Cord and Decreases Disease Severity in SMA Mice
Sofia Benkhelifa-Ziyyat et al.
MOLECULAR THERAPY (2013)
Spinal muscular atrophy: going beyond the motor neuron
Gillian Hamilton et al.
TRENDS IN MOLECULAR MEDICINE (2013)
The contribution of mouse models to understanding the pathogenesis of spinal muscular atrophy
James N. Sleigh et al.
DISEASE MODELS & MECHANISMS (2011)
Combination of SMN Trans-Splicing and a Neurotrophic Factor Increases the Life Span and Body Mass in a Severe Model of Spinal Muscular Atrophy
Monir Shababi et al.
HUMAN GENE THERAPY (2011)
Intravenous scAAV9 delivery of a codon-optimized SMN1 sequence rescues SMA mice
Elisa Dominguez et al.
HUMAN MOLECULAR GENETICS (2011)
Postsymptomatic restoration of SMN rescues the disease phenotype in a mouse model of severe spinal muscular atrophy
Cathleen M. Lutz et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
PTEN depletion rescues axonal growth defect and improves survival in SMN-deficient motor neurons
Ke Ning et al.
HUMAN MOLECULAR GENETICS (2010)
Systemic Delivery of scAAV9 Expressing SMN Prolongs Survival in a Model of Spinal Muscular Atrophy
Chiara F. Valori et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
Spinal muscular atrophy: why do low levels of survival motor neuron protein make motor neurons sick?
Arthur H. M. Burghes et al.
NATURE REVIEWS NEUROSCIENCE (2009)
Quantitative analyses of SMN1 and SMN2 based on real-time LightCycler PCR:: Fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy
M Feldkötter et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2002)
Share Paper
